Notice of Listing of Members of the National Institutes of Health's Senior Executive Service Performance Review Board (PRB), 46501 [E6-13209]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 156 / Monday, August 14, 2006 / Notices
irrelevant. The right to contest records
is limited to information which is
incomplete, irrelevant, incorrect, or
untimely (obsolete).
RECORD SOURCE CATEGORIES:
Inventors and other collaborating
persons, grantees, fellowship recipients
and contractors; other Federal agencies;
scientific experts from non-Government
organizations; contract patent counsel
and their employees and foreign
contract personnel; United States and
foreign patent offices; prospective
licensees; HHS Technology
Development Coordinators, Internet and
commercial databases, and third parties
whom HHS contacts to determine
individual invention ownership or
Government ownership.
SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS
OF THE ACT:
None.
[FR Doc. E6–13212 Filed 8–11–06; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jlentini on PROD1PC65 with NOTICES
Notice of Listing of Members of the
National Institutes of Health’s Senior
Executive Service Performance Review
Board (PRB)
The National Institutes of Health
(NIH) announces the persons who will
serve on the National Institutes of
Health’s Senior Executive Service
Performance Review Board. This action
is being taken in accordance with Title
5, U.S.C., Section 4314(c)(4), which
requires that members of performance
review boards be appointed in a manner
to ensure consistency, stability, and
objectivity in performance appraisals
and requires that notice of the
appointment of an individual to serve as
a member be published in the Federal
Register.
The following persons will serve on
the NIH Performance Review Board,
which oversees the evaluation of
performance appraisals of NIH Senior
Executive Service (SES) members:
Ms. Colleen Barros (Chair).
Dr. Norka Ruiz Bravo.
Dr. Michael Gottesman.
Dr. John Hallenbeck.
Ms. Lynn Hellinger.
Dr. Raynard Kington.
Dr. Lore Anne McNicol.
For further information about the NIH
Performance Review Board, contact the
Office of Human Resources, Workforce
Relations Division, National Institutes of
VerDate Aug<31>2005
17:58 Aug 11, 2006
Jkt 208001
Health, Building 31, Room B3C07,
Bethesda, Maryland 20892, telephone
301–402–9203 (not a toll-free number).
Dated: August 1, 2006.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. E6–13209 Filed 8–11–06; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of Laboratories Which
Meet Minimum Standards To Engage in
Urine Drug Testing for Federal
Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: The Department of Health and
Human Services (HHS) notifies Federal
agencies of the laboratories currently
certified to meet the standards of
Subpart C of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines). The
Mandatory Guidelines were first
published in the Federal Register on
April 11, 1988 (53 FR 11970), and
subsequently revised in the Federal
Register on June 9, 1994 (59 FR 29908),
on September 30, 1997 (62 FR 51118),
and on April 13, 2004 (69 FR 19644).
A notice listing all currently certified
laboratories is published in the Federal
Register during the first week of each
month. If any laboratory’s certification
is suspended or revoked, the laboratory
will be omitted from subsequent lists
until such time as it is restored to full
certification under the Mandatory
Guidelines.
If any laboratory has withdrawn from
the HHS National Laboratory
Certification Program (NLCP) during the
past month, it will be listed at the end,
and will be omitted from the monthly
listing thereafter.
This notice is also available on the
Internet at https://workplace.samhsa.gov
and https://www.drugfreeworkplace.gov.
FOR FURTHER INFORMATION CONTACT: Mrs.
Giselle Hersh or Dr. Walter Vogl,
Division of Workplace Programs,
SAMHSA/CSAP, Room 2–1035, 1 Choke
Cherry Road, Rockville, Maryland
20857; 240–276–2600 (voice), 240–276–
2610 (fax).
SUPPLEMENTARY INFORMATION: The
Mandatory Guidelines were developed
in accordance with Executive Order
12564 and section 503 of Pub. L. 100–
71. Subpart C of the Mandatory
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
46501
Guidelines, ‘‘Certification of
Laboratories Engaged in Urine Drug
Testing for Federal Agencies,’’ sets strict
standards that laboratories must meet in
order to conduct drug and specimen
validity tests on urine specimens for
Federal agencies. To become certified,
an applicant laboratory must undergo
three rounds of performance testing plus
an on-site inspection. To maintain that
certification, a laboratory must
participate in a quarterly performance
testing program plus undergo periodic,
on-site inspections.
Laboratories which claim to be in the
applicant stage of certification are not to
be considered as meeting the minimum
requirements described in the HHS
Mandatory Guidelines. A laboratory
must have its letter of certification from
HHS/SAMHSA (formerly: HHS/NIDA)
which attests that it has met minimum
standards.
In accordance with Subpart C of the
Mandatory Guidelines dated April 13,
2004 (69 FR 19644), the following
laboratories meet the minimum
standards to conduct drug and specimen
validity tests on urine specimens:
ACL Laboratories, 8901 W. Lincoln
Ave., West Allis, WI 53227, 414–328–
7840 / 800–877–7016, (Formerly:
Bayshore Clinical Laboratory).
ACM Medical Laboratory, Inc., 160
Elmgrove Park, Rochester, NY 14624,
585–429–2264.
Advanced Toxicology Network, 3560
Air Center Cove, Suite 101, Memphis,
TN 38118, 901–794–5770 / 888–290–
1150.
Aegis Analytical Laboratories, Inc., 345
Hill Ave., Nashville, TN 37210, 615–
255–2400.
Baptist Medical Center-Toxicology
Laboratory, 9601 I–630, Exit 7, Little
Rock, AR 72205–7299, 501–202–2783,
(Formerly: Forensic Toxicology
Laboratory Baptist Medical Center).
Clinical Reference Lab, 8433 Quivira
Road, Lenexa, KS 66215–2802, 800–
445–6917.
Diagnostic Services, Inc., dba DSI,
12700 Westlinks Drive, Fort Myers,
FL 33913, 239–561–8200 / 800–735–
5416.
Doctors Laboratory, Inc., 2906 Julia
Drive, Valdosta, GA 31602, 229–671–
2281.
DrugScan, Inc., P.O. Box 2969, 1119
Mearns Road, Warminster, PA 18974,
215–674–9310.
Dynacare Kasper Medical Laboratories*,
10150–102 St., Suite 200, Edmonton,
Alberta, Canada T5J 5E2, 780–451–
3702 / 800–661–9876.
ElSohly Laboratories, Inc., 5 Industrial
Park Drive, Oxford, MS 38655, 662–
236–2609.
E:\FR\FM\14AUN1.SGM
14AUN1
]]>Agencies
[Federal Register Volume 71, Number 156 (Monday, August 14, 2006)]
[Notices]
[Page 46501]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-13209]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Listing of Members of the National Institutes of
Health's Senior Executive Service Performance Review Board (PRB)
The National Institutes of Health (NIH) announces the persons who
will serve on the National Institutes of Health's Senior Executive
Service Performance Review Board. This action is being taken in
accordance with Title 5, U.S.C., Section 4314(c)(4), which requires
that members of performance review boards be appointed in a manner to
ensure consistency, stability, and objectivity in performance
appraisals and requires that notice of the appointment of an individual
to serve as a member be published in the Federal Register.
The following persons will serve on the NIH Performance Review
Board, which oversees the evaluation of performance appraisals of NIH
Senior Executive Service (SES) members:
Ms. Colleen Barros (Chair).
Dr. Norka Ruiz Bravo.
Dr. Michael Gottesman.
Dr. John Hallenbeck.
Ms. Lynn Hellinger.
Dr. Raynard Kington.
Dr. Lore Anne McNicol.
For further information about the NIH Performance Review Board,
contact the Office of Human Resources, Workforce Relations Division,
National Institutes of Health, Building 31, Room B3C07, Bethesda,
Maryland 20892, telephone 301-402-9203 (not a toll-free number).
Dated: August 1, 2006.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. E6-13209 Filed 8-11-06; 8:45 am]
BILLING CODE 4140-01-P
